Invesco Ltd. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 56 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2023$436,042
-3.3%
425,0000.0%0.00%
Q4 2022$451,053
+7.1%
425,0000.0%0.00%
Q3 2022$421,0000.0%425,0000.0%0.00%
Q2 2022$421,000
-0.9%
425,0000.0%0.00%
Q1 2022$425,000
-4.3%
425,0000.0%0.00%
Q4 2021$444,000
+2.1%
425,0000.0%0.00%
Q3 2021$435,000
-1.1%
425,0000.0%0.00%
Q2 2021$440,000
-40.1%
425,000
-41.4%
0.00%
Q1 2021$734,000
-5.7%
725,0000.0%0.00%
Q4 2020$778,000
+2.2%
725,0000.0%0.00%
Q3 2020$761,000
-37.7%
725,000
-27.5%
0.00%
Q2 2020$1,222,000
+16.6%
1,000,0000.0%0.00%
Q1 2020$1,048,000
-0.9%
1,000,0000.0%0.00%
Q4 2019$1,057,000
-34.8%
1,000,000
-39.4%
0.00%
Q3 2019$1,622,000
-5.3%
1,650,0000.0%0.00%
Q2 2019$1,713,000
-37.6%
1,650,000
-38.5%
0.00%
-100.0%
Q1 2019$2,747,000
+2.9%
2,685,0000.0%0.00%0.0%
Q4 2018$2,670,000
-1.2%
2,685,000
+5.9%
0.00%0.0%
Q3 2018$2,702,000
+158.3%
2,535,000
+144.9%
0.00%
Q2 2018$1,046,0001,035,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 53,670$57,726,0003.34%
SHENKMAN CAPITAL MANAGEMENT INC 26,959,000$29,149,0003.04%
ADVENT CAPITAL MANAGEMENT /DE/ 84,134,000$90,539,0001.93%
Cheyne Capital Management (UK) LLP 3,220,000$3,452,0001.75%
PFM Health Sciences, LP 40,300,000$43,210,0001.52%
Sonora Investment Management, LLC 6,370,000$6,807,0000.56%
MACKAY SHIELDS LLC 66,018,000$70,980,0000.49%
ZAZOVE ASSOCIATES LLC 1,500,000$1,608,0000.20%
IRON Financial LLC 275,000$295,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$3,216,0000.08%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders